Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
life sciences
national blog main
accelerated approval
acute hepatic porphyria
alnylam pharmaceuticals
aminolevulinic acid
biontech
boehringer ingelheim
clinical trials
curevac
deals
drugs
eli lilly
givosiran
infectious diseases
john shiver
moderna therapeutics
mrna
new york blog main
new york top stories
rna interference
san francisco blog main
san francisco top stories
sanofi
translate bio
vaccines
What
new
2
×
rna
2
×
second
alnylam
bets
bio
cancer
cleared
comes
companies
cut
data
date
deal
drug
effective
enticed
evidence
far
hasn’t
interference
latest
market
medicine
medicines
messenger
molecules
mrna
multiple
nasdaq
ok
pharmaceutical
pharmaceuticals
primarily
promise
proven
rnai
sanofi
seek
source
Language
Current search:
boston
×
new
×
rna
×
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
